New Oral Vaccine for UTIs Keeps Patients Infection-Free for Up to Nine Years, Study Finds

Researchers say the majority of patients who received a new oral vaccine for recurrent urinary tract infections remained UTI-free for up to nine years with few side effects.

An oral vaccine currently being tested for recurrent urinary tract infections may help reduce the use of antibiotics.

Researchers say the vaccine kept the majority of patients in a new study UTI-free for up to nine years with no notable side effects.

89 men and women received the vaccine, which is administered with two sprays of a pineapple flavored suspension under the tongue every day for three months.

Long-term prevention was achieved in 54% of them, according to the results.

And many of those who did get a UTI reported that drinking plenty of water was enough to treat it.

UTIs are painful and often require antibiotics during a time when resistance is on the rise.

While more research is needed, one author says this “data suggests [the vaccine] could be a game changer for UTI prevention if it’s offered widely, reducing the need for antibiotic treatments.”

Related Stories

No stories found.
logo
www.healthday.com